← Back to Search

Behavioural Intervention

MyVoice:Rheum for Rheumatic Diseases

N/A
Waitlist Available
Led By Mehret S Birru Talabi, MD, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients must read and speak in English as a Spanish-language version of the tool has not yet been developed
Patients must have at least one of four rheumatic diseases diagnosed by a rheumatologist: rheumatoid arthritis (RA), systemic sclerosis (SSc), myositis, and systemic lupus erythematosus (SLE).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up t3 (3 months post intervention)
Awards & highlights

Study Summary

This trial will compare the feasibility and acceptability of MyVoice (an app) to a patient pamphlet among female patients ages 18-44.

Eligible Conditions
  • Rheumatic Diseases
  • Physician-Patient Relationship
  • Birth Control

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~t2 (within 24 hours of intervention and appointment); t3 (three months post-intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and t2 (within 24 hours of intervention and appointment); t3 (three months post-intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of Intervention
Intervention Appropriateness Measure
Perceived Value of Tool to Providers
+1 more
Other outcome measures
Attitudes on rheumatic medications and pregnancy
Change in Pregnancy Intention
Decisional Conflict
+12 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: RheumatologistsExperimental Treatment1 Intervention
Rheumatologists who interact with patients who have used the MyVoice: Rheum decision aid
Group II: Decision Aid UsersExperimental Treatment1 Intervention
Patients with a rheumatic disease who are given access to the MyVoice:Rheum decision aid
Group III: Pamphlet UsersActive Control1 Intervention
Patients with a rheumatic disease who are given access to a widely-accessible pamphlet about family planning

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,712 Previous Clinical Trials
16,346,365 Total Patients Enrolled
1 Trials studying Rheumatic Diseases
359 Patients Enrolled for Rheumatic Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
483 Previous Clinical Trials
1,086,900 Total Patients Enrolled
6 Trials studying Rheumatic Diseases
8,826 Patients Enrolled for Rheumatic Diseases
Mehret S Birru Talabi, MD, PhDPrincipal InvestigatorUniversity of Pittsburgh

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial take into consideration individuals aged 25 or over?

"According to the study's enrollment prerequisites, those that are 18 years old or older and younger than 44 qualify for inclusion in this trial."

Answered by AI

Is it feasible for me to enroll in this research effort?

"This medical study is seeking 50 volunteers aged 18 to 44 with a rheumatic disorder. Eligible participants must have at least one of four conditions certified by a specialist in arthritis: Rheumatoid arthritis (RA), Systemic Sclerosis (SSc), Myositis, and Systemic Lupus Erythematosus (SLE). Additionally, individuals should be fluent in English as no Spanish-language version exists yet; they will also require access to either a mobile phone, laptop or tablet."

Answered by AI

Is the research team actively seeking new participants for this experiment?

"Clinicaltrials.gov demonstrates that this medical trial is currently enlisting participants, as it has been ongoing since July 29th 2021 and was recently modified on September 7th 2022."

Answered by AI

What is the capacity of participants for this experiment?

"Affirmative. Clinicaltrials.gov has confirmed that this trial is currently open for recruitment, having been first posted on July 29th 2021 and updated as recently as September 7th 2022. This research programme seeks to enrol 50 individuals across 2 sites."

Answered by AI
~13 spots leftby Mar 2025